News ArchivesRead News
Variants in three estrogen-related genes linked to Parkinson’s disease in women
Wednesday November 22, 2006
11/20/06(Mayo Clinic) - Researchers at Mayo Clinic have discovered a possible connection between increased risk for Parkinson’s disease and variants in three genes that control estrogen production and activity in the body.
“We and other investigators have found evidence that estrogen helps protect women from developing Parkinson’s," says Walter Rocca, at Mayo Clinic and lead study investigator. " So, a gene variant that would decrease estrogen production or activity would put those women at greater risk for the disease."
The study associated variants in the following three genes with development of Parkinson’s: estrogen receptor 1 gene ( ESR1 ); estrogen receptor 2 gene ( ESR2 ); and PR domain-containing protein 2 gene ( PRDM2 ).
" The gene variants are not a defect or a problem in and of themselves -- they are part of human differences, simply differences across people," says Rocca. " These differences make one subgroup of the population more susceptible to a disease like Parkinson’s. However, sometimes the genetic variant is a weak risk factor, and the disease only manifests if another risk factor is present, such as a particular diet, physical exercise, taking certain medications or a medical event."
The study was conducted using a database from a previous study of the entire human genome for genes linked to Parkinson’s. For the new study, the Mayo Clinic investigators examined several genes for variants in 172 women who had Parkinson’s and 229 women who did not have the disease.
Rocca explains that some genetic variants the study pinpointed for association with Parkinson’s are quite common, affecting 10 to 20 percent of the female population. As women are not routinely tested for these gene variations, however, those affected would be unaware, he says.
" If the findings of this study are replicated and confirmed, the hope is to use these variants to predict the risk of disease using a simple blood test," says Rocca. He explains that the test would be particularly useful for women and their physicians before deciding to conduct an elective ovariectomy, surgical removal of the ovaries, because a combination of estrogen-reducing factors could amplify a woman’s risk for Parkinson’s.
Recent NewsMar 27 - March 27, 2018 News Update
Mar 20 - March 20, 2018 News Update
Mar 13 - March 13, 2018 News Update
Mar 6 - March 6, 2018 News Update
Feb 27 - February 27, 2018 News Update
Feb 20 - February 20, 2018 News Update
Feb 13 - February 13, 2018 News Update
Feb 6 - February 6, 2018 News Update
Jan 30 - January 30, 2018 News Update
Jan 23 - January 23, 2018 News Update
Jan 16 - January 16, 2018 News Update
Jan 9 - January 9, 2018 News Update
Jan 2 - January 2, 2018 News Update
Dec 26 - December 26, 2017 News Update
Dec 19 - December 19, 2017 News Update
Dec 8 - New technique scours the genome for genes that combat disease
Dec 8 - Restless sleep may be an early sign of Parkinson's, dementia
Dec 1 - Defects in cell's 'waste disposal system' linked to Parkinson's
Dec 1 - Dual virtual reality/treadmill exercises promote brain plasticity in Parkinson's patients
Nov 17 - 'Moving Day' participant is not letting young-onset Parkinson's disease stop him